- Investing Ideas
- /
- Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
8
Companies with a Value score of at least 3, ordered by Value score
8 companies
Merck
Market Cap: US$199.7b
Operates as a healthcare company worldwide.
MRK
US$81.10
7D
0%
1Y
-28.6%
Regeneron Pharmaceuticals
Market Cap: US$58.9b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$596.50
7D
5.5%
1Y
-43.9%
Bristol-Myers Squibb
Market Cap: US$91.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$46.60
7D
0%
1Y
-8.8%
Pfizer
Market Cap: US$137.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$24.14
7D
0.04%
1Y
-16.0%
Johnson & Johnson
Market Cap: US$425.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$175.50
7D
-1.7%
1Y
6.4%
Thermo Fisher Scientific
Market Cap: US$177.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$482.00
7D
-0.2%
1Y
-20.7%
Gilead Sciences
Market Cap: US$141.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.25
7D
0%
1Y
33.2%
Amgen
Market Cap: US$154.4b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$264.80
7D
0%
1Y
-20.6%